Research and development expenses were $11.4 million for the third quarter ended September 30, 2024, compared to $11.7 million for the comparable period in 2023. The decrease was primarily related to ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that President and CEO Lisa ...

Generally, the disease is categorized by three stages, which serve as a guide and mark disease progression based on its symptoms. They are mild (early), moderate (middle), and severe (late) stage AD.

Their research, published in Bioengineering & Translational Medicine, indicates that this novel method could result in a new treatment option in an area of medicine that currently has few, if any ...

Designed to provide broad exposure to the Large Cap Blend segment of the US equity market, the Invesco Dow Jones Industrial Average Dividend ETF (DJD) is a passively managed exchange traded fund ...

Standard AP and lateral radiographs of the right hip (Figure 1) and an AP pelvis (Figure 2) demonstrate collapse of the femoral head with mild degenerative changes of the acetabulum. On MRI the ...

The researchers developed novel contrast agents that target two proteins implicated in osteoarthritis, a degenerative joint disease commonly characterized as wear-and-tear arthritis. By marking ...

The Mother Monster is back. Marking her return to the peak pop form that put her on the map, Lady Gaga has shared a new song, “Disease,” the first single from her forthcoming album. Stream it below.

Behold, the start of an era. Lady Gaga has just dropped the first single for her upcoming seventh album, giving us a taste of what to expect from her new music. Titled “Disease,” the ...

Lady Gaga is so back. After a four year hiatus from new solo music since the release of her last studio album, 2020's Chromatica, Mother Monster has returned. On Friday at midnight, the Grammy and ...